Zurich Cantonal Bank’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,184
Closed -$56.2K 2561
2025
Q3
$56.2K Hold
2,184
﹤0.01% 2442
2025
Q2
$126K Hold
2,184
﹤0.01% 2315
2025
Q1
$236K Hold
2,184
﹤0.01% 2012
2024
Q4
$104K Hold
2,184
﹤0.01% 2420
2024
Q3
$215K Hold
2,184
﹤0.01% 2068
2024
Q2
$357K Hold
2,184
﹤0.01% 1725
2024
Q1
$333K Hold
2,184
﹤0.01% 1741
2023
Q4
$685K Buy
2,184
+256
+13% +$92.7K ﹤0.01% 1297
2023
Q3
$856K Buy
1,928
+294
+18% +$133K ﹤0.01% 1058
2023
Q2
$709K Buy
1,634
+520
+47% +$292K ﹤0.01% 1144
2023
Q1
$662K Buy
1,114
+102
+10% +$57.1K ﹤0.01% 1136
2022
Q4
$408K Sell
1,012
-14
-1% -$6.57K ﹤0.01% 1369
2022
Q3
$600K Buy
1,026
+79
+8% +$47.3K ﹤0.01% 1071
2022
Q2
$517K Buy
+947
New +$479K ﹤0.01% 1210

Other funds holding AGL

Zurich Cantonal Bank's AGL Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 2,184 shares — an estimated $56.2K sold.

Zurich Cantonal Bank first reported a position in AGL in Q2 2022 and held it in 14 quarters. The position peaked at $856K in Q3 2023. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 2,184 Agilon Health shares in Q4 2025, an estimated $56.2K.
  • Zurich Cantonal Bank first reported a position in Agilon Health in Q2 2022 and held it in 14 quarters.
  • Zurich Cantonal Bank's Agilon Health position peaked at $856K in Q3 2023.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.